Alphamab Oncology (Stock Code: 9966.HK) announced that the results from a phase III clinical study for the treatment of HER2-positive gastric or gastroesophageal junction cancer (GC/GEJ) of ...

Phase II Dose-Randomized Study of Sunvozertinib in Platinum-Pretreated Non–Small Cell Lung Cancer With Epidermal Growth Factor Receptor Exon 20 Insertion Mutations (WU-KONG1B) Patients with unresected ...

A new randomized clinical trial showed that receiving immunochemotherapy infusions earlier in the day may help patients with ...

The study, which assessed the pharmacokinetics, safety, tolerability and immunogenicity of AVT80 compared to Entyvio® in ...

The U.S. is giving $1.6 million to researchers to study how the hepatitis B vaccine affects newborns in Guinea-Bissau. Local ...

Investigators based at Monash Children's Hospital and Royal Children's Hospital Melbourne report that a once-daily intranasal ...

Abemaciclib Plus Fulvestrant in Advanced Breast Cancer After Progression on CDK4/6 Inhibition: Results From the Phase III postMONARCH Trial Patients with stage III to IV or recurrent, radiographically ...

Results from the largest-ever clinical trial of its kind found administering a synthetic protein can reduce bleeding and improve outcomes for certain patients at the highest risk of continued bleeding ...

Current drugs for pancreatic cancer lose effectiveness within months because the tumour becomes resistant. The group from ...

By Dr. Sanchari Sinha Dutta, Ph.D. A year of consistent aerobic activity didn’t just boost fitness; it shifted MRI -based brain age in early to midlife adults, suggesting exercise may help preserve ...